Pomalidomide improves airway inflammation and mucus hypersecretion in COPD rats by inhibiting TNF-α / NF-κB signaling pathway
Basic Research|更新时间:2024-02-08
|
Pomalidomide improves airway inflammation and mucus hypersecretion in COPD rats by inhibiting TNF-α / NF-κB signaling pathway
Medical Journal of Chinese People′s Liberation ArmyVol. 49, Issue 1, Pages: 91-98(2024)
作者机构:
1.河南中医药大学河南省中医药防治呼吸病重点实验室,河南郑州 450046
2.河南中医药大学呼吸疾病中医药防治省部共建协同创新中心,河南郑州 450046
3.河南中医药大学第一附属医院中药药理(呼吸)实验室,河南郑州 450000
作者简介:
E-mail: lisuyun2000@126.com
基金信息:
the National Natural Science Foundation of China(82074413;81874433);the National Key Research and Development Program(2018YFC1704801);the Inheritance and Innovation of Chinese Medicine "thousand million" Talent Project (Qihuang Project)([2018]284号);the Zhongyuan Thousand Talents Plan Project(202101510002)
Liu Shu-Juan,Li Ya,Fan Zheng-Yuan,et al.Pomalidomide improves airway inflammation and mucus hypersecretion in COPD rats by inhibiting TNF-α / NF-κB signaling pathway[J].Medical Journal of Chinese People′s Liberation Army,2024,49(01):91-98.
Liu Shu-Juan,Li Ya,Fan Zheng-Yuan,et al.Pomalidomide improves airway inflammation and mucus hypersecretion in COPD rats by inhibiting TNF-α / NF-κB signaling pathway[J].Medical Journal of Chinese People′s Liberation Army,2024,49(01):91-98. DOI: 10.11855/j.issn.0577-7402.0155.2023.0619.
Pomalidomide improves airway inflammation and mucus hypersecretion in COPD rats by inhibiting TNF-α / NF-κB signaling pathway